This late-breaking clinical trials session showcases novel therapies and technologies advancing the treatment of atrial and ventricular arrhythmias. Presentations include first-in-human and multicenter clinical data on wearable neuromodulation following pulse field ablation, next-generation pulse field ablation techniques, innovative lesion creation strategies for ventricular tachycardia, map-guided redo ablation for persistent atrial fibrillation, and 4D intracardiac echocardiography to support left atrial appendage closure and concomitant ablation procedures. Together, these studies highlight emerging approaches designed to improve procedural precision, safety, and long-term rhythm outcomes in electrophysiology.
Late-Breaking Clinical Trials: Innovations in Ablation & Electrophysiology Technologies
September 20, 2026 | 09:35 AM (EDT) - 10:35 AM (EDT)